Navamedic ASA Financial report for Q1 2012
(Thomson Reuters ONE) -
Navamedic's first quarter 2012 revenues saw a 22 per cent growth over the same
period last year. Revenues were NOK 20.6 million compared to NOK 16.8 million in
2011. EBITDA for the first quarter reached NOK 0.1 million, compared to NOK -1.0
million in the same period of 2011. Eight generic products are authorized for
marketing in the last two quarters of 2012.
Group Group
(in NOK '000) Q1 2012 Q1 2011 FY 2011
Revenues 20.588 16.778 71.299
Gross Profit 8.265 6.672 29.272
Gross margin 40% 40% 41%
EBITDA 58 -982 -2.639
EBIT -1.500 -2.669 -9.359
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
The full report with tables and the presentation can be downloaded from the
following links:
Navamedic ASA Q1 2012 presentation:
http://hugin.info/136020/R/1608699/510653.pdf
Navamedic ASA Q1 2012 report:
http://hugin.info/136020/R/1608699/510651.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Navamedic ASA via Thomson Reuters ONE
[HUG#1608699]
Unternehmensinformation / Kurzprofil:
Datum: 03.05.2012 - 19:06 Uhr
Sprache: Deutsch
News-ID 142576
Anzahl Zeichen: 1837
contact information:
Town:
Lysaker
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 171 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Navamedic ASA Financial report for Q1 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
Navamedic ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
